In addition, only a preliminary study of the mechanism has been carried out, and a larger sample size is still needed to analyze the specific relationship between PRG4 inhibition of cancer cell migration and the prognosis of HCC patients. Here, PRG4 is linked to hepatocellular carcinoma.